메뉴 건너뛰기




Volumn 7, Issue 3, 2015, Pages 344-361

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs

Author keywords

Abatacept; Anti TNF; Biologics; Hepatitis B virus; Rheumatoid arthritis; Rituximab; Tocilizumab

Indexed keywords


EID: 84928946211     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i3.344     Document Type: Article
Times cited : (62)

References (111)
  • 1
    • 84875885446 scopus 로고    scopus 로고
    • Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis
    • PMID: 23511719
    • Navarro-Millán I, Curtis JR. Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis. Curr Opin Rheumatol 2013; 25: 384-390 [PMID: 23511719 DOI: 10.1097/BOR.0b013e32835fc62e]
    • (2013) Curr Opin Rheumatol , vol.25 , pp. 384-390
    • Navarro-Millán, I.1    Curtis, J.R.2
  • 3
    • 84876274224 scopus 로고    scopus 로고
    • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012
    • Furst DE, Keystone EC, So AK, Braun J, Breedveld FC, Burmester GR. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. Ann Rheum Dis 2013; 72 Suppl 2: ii2-34 [DOI: 10.1136/annrheumdis-2013-20334]
    • (2013) Ann Rheum Dis , vol.72 , pp. ii2-ii34
    • Furst, D.E.1    Keystone, E.C.2    So, A.K.3    Braun, J.4    Breedveld, F.C.5    Burmester, G.R.6
  • 6
    • 80055082433 scopus 로고    scopus 로고
    • Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety
    • PMID: 21906424
    • Favalli EG, Caporali R, Sinigaglia L, Pipitone N, Miniati I, Montecucco C, Matucci-Cerinic M. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety. Clin Exp Rheumatol 2011; 29:S15-S27 [PMID: 21906424]
    • (2011) Clin Exp Rheumatol , vol.29 , pp. S15-S27
    • Favalli, E.G.1    Caporali, R.2    Sinigaglia, L.3    Pipitone, N.4    Miniati, I.5    Montecucco, C.6    Matucci-Cerinic, M.7
  • 7
    • 79957790183 scopus 로고    scopus 로고
    • Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis
    • PMID: 21496415
    • Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis. Int J Immunopathol Pharmacol 2011; 24:269-274 [PMID: 21496415]
    • (2011) Int J Immunopathol Pharmacol , vol.24 , pp. 269-274
    • Benucci, M.1    Saviola, G.2    Baiardi, P.3    Manfredi, M.4    Sarzi-Puttini, P.5    Atzeni, F.6
  • 8
    • 77950862612 scopus 로고    scopus 로고
    • Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha
    • PMID: 20082236
    • De Stefano R, Frati E, Nargi F, Baldi C, Menza L, Hammoud M, Galeazzi M. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha. Clin Rheumatol 2010; 29: 517-524 [PMID: 20082236 DOI: 10.1007/s10067-009-1349-y]
    • (2010) Clin Rheumatol , vol.29 , pp. 517-524
    • De Stefano, R.1    Frati, E.2    Nargi, F.3    Baldi, C.4    Menza, L.5    Hammoud, M.6    Galeazzi, M.7
  • 9
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • PMID:16385520
    • Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006; 54: 26-37 [PMID:16385520]
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    van Vollenhoven, R.6    Sharp, J.7    Perez, J.L.8    Spencer-Green, G.T.9
  • 11
    • 0025373939 scopus 로고
    • High-dose corticosteroids during bleomycin-induced alveolitis in the rat do not suppress the accumulation of hyaluronan (hyaluronic acid) in lung tissue
    • PMID: 1694778
    • Nettelbladt O, Tengblad A, Hällgren R. High-dose corticosteroids during bleomycin-induced alveolitis in the rat do not suppress the accumulation of hyaluronan (hyaluronic acid) in lung tissue. Eur Respir J 1990; 3: 421-428 [PMID: 1694778]
    • (1990) Eur Respir J , vol.3 , pp. 421-428
    • Nettelbladt, O.1    Tengblad, A.2    Hällgren, R.3
  • 12
    • 84887426711 scopus 로고    scopus 로고
    • Biologic and oral diseasemodifying antirheumatic drug monotherapy in rheumatoid arthritis
    • PMID: 23918035
    • Emery P, Sebba A, Huizinga TW. Biologic and oral diseasemodifying antirheumatic drug monotherapy in rheumatoid arthritis. Ann Rheum Dis 2013; 72: 1897-1904 [PMID: 23918035 DOI:10.1136/annrheumdis-2013-203485]
    • (2013) Ann Rheum Dis , vol.72 , pp. 1897-1904
    • Emery, P.1    Sebba, A.2    Huizinga, T.W.3
  • 13
    • 48149100741 scopus 로고    scopus 로고
    • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
    • PMID: 18635256
    • Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008; 372: 375-382 [PMID: 18635256 DOI: 10.1016/ S0140-6736(08)61000-4]
    • (2008) Lancet , vol.372 , pp. 375-382
    • Emery, P.1    Breedveld, F.C.2    Hall, S.3    Durez, P.4    Chang, D.J.5    Robertson, D.6    Singh, A.7    Pedersen, R.D.8    Koenig, A.S.9    Freundlich, B.10
  • 14
    • 85027919018 scopus 로고    scopus 로고
    • Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
    • PMID: 22562973
    • Kavanaugh A, Fleischmann RM, Emery P, Kupper H, Redden L, Guerette B, Santra S, Smolen JS. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Ann Rheum Dis 2013; 72:64-71 [PMID: 22562973 DOI: 10.1136/annrheumdis-2011-201247]
    • (2013) Ann Rheum Dis , vol.72 , pp. 64-71
    • Kavanaugh, A.1    Fleischmann, R.M.2    Emery, P.3    Kupper, H.4    Redden, L.5    Guerette, B.6    Santra, S.7    Smolen, J.S.8
  • 15
    • 0037244694 scopus 로고    scopus 로고
    • The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebocontrolled trials
    • Oxford, PMID:12509606
    • Jones G, Halbert J, Crotty M, Shanahan EM, Batterham M, Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebocontrolled trials. Rheumatology (Oxford) 2003; 42: 6-13 [PMID:12509606]
    • (2003) Rheumatology , vol.42 , pp. 6-13
    • Jones, G.1    Halbert, J.2    Crotty, M.3    Shanahan, E.M.4    Batterham, M.5    Ahern, M.6
  • 16
    • 0037231475 scopus 로고    scopus 로고
    • Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years:results from a large observational inception study
    • PMID: 12528102
    • Bukhari MA, Wiles NJ, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years:results from a large observational inception study. Arthritis Rheum 2003; 48: 46-53 [PMID: 12528102]
    • (2003) Arthritis Rheum , vol.48 , pp. 46-53
    • Bukhari, M.A.1    Wiles, N.J.2    Lunt, M.3    Harrison, B.J.4    Scott, D.G.5    Symmons, D.P.6    Silman, A.J.7
  • 17
    • 0028808715 scopus 로고
    • Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study
    • PMID:8835550
    • Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995; 22: 2208-2213 [PMID:8835550]
    • (1995) J Rheumatol , vol.22 , pp. 2208-2213
    • Egsmose, C.1    Lund, B.2    Borg, G.3    Pettersson, H.4    Berg, E.5    Brodin, U.6    Trang, L.7
  • 18
    • 77953122551 scopus 로고    scopus 로고
    • Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs
    • PMID: 20223500
    • Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum 2010; 39: 425-441 [PMID: 20223500 DOI: 10.1016/j.semarthrit.2009.12.002]
    • (2010) Semin Arthritis Rheum , vol.39 , pp. 425-441
    • Bergman, G.J.1    Hochberg, M.C.2    Boers, M.3    Wintfeld, N.4    Kielhorn, A.5    Jansen, J.P.6
  • 19
    • 78751704593 scopus 로고    scopus 로고
    • Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
    • Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Ann Rheum Dis 2011; 70 Suppl 2: 266-271 [DOI:10.1136/ard.2010.132134]
    • (2011) Ann Rheum Dis , vol.70 , pp. 266-271
    • Salliot, C.1    Finckh, A.2    Katchamart, W.3    Lu, Y.4    Sun, Y.5    Bombardier, C.6    Keystone, E.7
  • 20
    • 79251471130 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
    • PMID:21039421
    • Mewar D, Wilson AG. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br J Pharmacol 2011; 162: 785-791 [PMID:21039421 DOI: 10.1111/j.1476-5381.2010.01099.x]
    • (2011) Br J Pharmacol , vol.162 , pp. 785-791
    • Mewar, D.1    Wilson, A.G.2
  • 21
    • 84863846460 scopus 로고    scopus 로고
    • Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis:systematic review and indirect pairwise meta-analysis
    • PMID: 22294630
    • Schoels M, Aletaha D, Smolen JS, Wong JB. Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis:systematic review and indirect pairwise meta-analysis. Ann Rheum Dis 2012; 71: 1303-1308 [PMID: 22294630 DOI: 10.1136/ annrheumdis-2011-20049]
    • (2012) Ann Rheum Dis , vol.71 , pp. 1303-1308
    • Schoels, M.1    Aletaha, D.2    Smolen, J.S.3    Wong, J.B.4
  • 22
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    • PMID: 14996343
    • Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107 [PMID: 14996343]
    • (2004) J Viral Hepat , vol.11 , pp. 97-107
    • Lavanchy, D.1
  • 24
    • 84867873277 scopus 로고    scopus 로고
    • Viral hepatitis: global goals for vaccination
    • PMID: 22999800
    • Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol 2012; 55: 296-302 [PMID: 22999800]
    • (2012) J Clin Virol , vol.55 , pp. 296-302
    • Lavanchy, D.1
  • 26
    • 77954650414 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B
    • PMID: 20638020
    • McMahon BJ. Natural history of chronic hepatitis B. Clin Liver Dis 2010; 14: 381-396 [PMID: 20638020 DOI: 10.1016/ j.cld.2010.05.007]
    • (2010) Clin Liver Dis , vol.14 , pp. 381-396
    • McMahon, B.J.1
  • 27
    • 0035818616 scopus 로고    scopus 로고
    • Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus
    • PMID:11694101
    • McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135: 759-768 [PMID:11694101]
    • (2001) Ann Intern Med , vol.135 , pp. 759-768
    • McMahon, B.J.1    Holck, P.2    Bulkow, L.3    Snowball, M.4
  • 28
    • 77951439226 scopus 로고    scopus 로고
    • Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
    • PMID: 20087968
    • Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010; 51:1531-1537 [PMID: 20087968 DOI: 10.1002/hep.23464]
    • (2010) Hepatology , vol.51 , pp. 1531-1537
    • Simonetti, J.1    Bulkow, L.2    McMahon, B.J.3    Homan, C.4    Snowball, M.5    Negus, S.6    Williams, J.7    Livingston, S.E.8
  • 30
    • 70249091404 scopus 로고    scopus 로고
    • Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection
    • PMID: 19664841
    • Chemin I, Guillaud O, Queyron PC, Trépo C. Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection. J Hepatol 2009; 51: 824-825 [PMID: 19664841 DOI: 10.1016/ j.jhep.2009.06.007]
    • (2009) J Hepatol , vol.51 , pp. 824-825
    • Chemin, I.1    Guillaud, O.2    Queyron, P.C.3    Trépo, C.4
  • 31
    • 84855712469 scopus 로고    scopus 로고
    • Molecular mechanisms underlying occult hepatitis B virus infection
    • PMID: 22232374
    • Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 2012; 25: 142-163 [PMID: 22232374 DOI: 10.1128/CMR.00018-11]
    • (2012) Clin Microbiol Rev , vol.25 , pp. 142-163
    • Samal, J.1    Kandpal, M.2    Vivekanandan, P.3
  • 32
    • 53049107213 scopus 로고    scopus 로고
    • HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma
    • PMID: 18722377
    • Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008; 135: 1192-1199 [PMID: 18722377 DOI:10.1053/j.gastro.2008.07.008]
    • (2008) Gastroenterology , vol.135 , pp. 1192-1199
    • Yuen, M.F.1    Wong, D.K.2    Fung, J.3    Ip, P.4    But, D.5    Hung, I.6    Lau, K.7    Yuen, J.C.8    Lai, C.L.9
  • 33
    • 84862664371 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
    • PMID: 22436845
    • American Association for the Study of Liver Diseases, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-185 [PMID: 22436845 DOI: 10.1016/ j.jhep.2012.02.010]
    • (2012) J Hepatol , vol.57 , pp. 167-185
  • 34
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: update 2009
    • PMID: 19714720
    • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662 [PMID: 19714720]
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 36
    • 66149190943 scopus 로고    scopus 로고
    • Reactivation of hepatitis B
    • PMID: 19399803
    • Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49:S156-S165 [PMID: 19399803 DOI: 10.1002/hep.22945]
    • (2009) Hepatology , vol.49 , pp. S156-S165
    • Hoofnagle, J.H.1
  • 37
    • 84871671108 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation associated with anti-neoplastic therapy
    • PMID: 23020594
    • Yeo W, Chan HL. Hepatitis B virus reactivation associated with anti-neoplastic therapy. J Gastroenterol Hepatol 2013; 28: 31-37 [PMID: 23020594 DOI: 10.1111/j.1440-1746.2012.07280.x]
    • (2013) J Gastroenterol Hepatol , vol.28 , pp. 31-37
    • Yeo, W.1    Chan, H.L.2
  • 39
    • 80855130599 scopus 로고    scopus 로고
    • Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes
    • PMID: 22075282
    • Vassilopoulos D. Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes. Eur J Intern Med 2011; 22: 572-575 [PMID: 22075282 DOI: 10.1016/ j.ejim.2011.09.00]
    • (2011) Eur J Intern Med , vol.22 , pp. 572-575
    • Vassilopoulos, D.1
  • 40
    • 84855172814 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis
    • PMID: 22150039
    • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-2219 [PMID: 22150039 DOI:10.1056/NEJMra1004965]
    • (2011) N Engl J Med , vol.365 , pp. 2205-2219
    • McInnes, I.B.1    Schett, G.2
  • 42
    • 84893737647 scopus 로고    scopus 로고
    • Targeting of interleukin-6 for the treatment of rheumatoid arthritis: a review and update
    • Tanaka T, Ogata A, Kishimoto T. Targeting of interleukin-6 for the treatment of rheumatoid arthritis: a review and update. Rheumatol Curr Res 2013; S4: 002
    • (2013) Rheumatol Curr Res , vol.S4 , pp. 002
    • Tanaka, T.1    Ogata, A.2    Kishimoto, T.3
  • 43
    • 59249104722 scopus 로고    scopus 로고
    • Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium
    • PMID: 19143467
    • Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009; 6: e1 [PMID: 19143467 DOI: 10.1371/journal.pmed.006000]
    • (2009) PLoS Med , vol.6 , pp. e1
    • Humby, F.1    Bombardieri, M.2    Manzo, A.3    Kelly, S.4    Blades, M.C.5    Kirkham, B.6    Spencer, J.7    Pitzalis, C.8
  • 45
    • 84876430054 scopus 로고    scopus 로고
    • Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
    • PMID:23596257
    • Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Postgrad Med J 2013; 89: 294-304 [PMID:23596257 DOI: 10.1136/postgradmedj-2011-301073rep]
    • (2013) Postgrad Med J , vol.89 , pp. 294-304
    • Bertoletti, A.1    Ferrari, C.2
  • 46
    • 84904681494 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model
    • PMID: 25047809
    • Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, Hsu PN. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One 2014; 9: e103008 [PMID: 25047809 DOI:10.1371/journal.pone.0103008]
    • (2014) PLoS One , vol.9 , pp. e103008
    • Tzeng, H.T.1    Tsai, H.F.2    Chyuan, I.T.3    Liao, H.J.4    Chen, C.J.5    Chen, P.J.6    Hsu, P.N.7
  • 47
    • 0031594577 scopus 로고    scopus 로고
    • A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection
    • PMID:9528902
    • Höhler T, Kruger A, Gerken G, Schneider PM, Meyer zum Büschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582 [PMID:9528902]
    • (1998) Clin Exp Immunol , vol.111 , pp. 579-582
    • Höhler, T.1    Kruger, A.2    Gerken, G.3    Schneider, P.M.4    Meyerzum Büschenefelde, K.H.5    Rittner, C.6
  • 48
    • 35648968689 scopus 로고    scopus 로고
    • PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients
    • PMID: 17868872
    • Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008; 45: 963-970 [PMID: 17868872]
    • (2008) Mol Immunol , vol.45 , pp. 963-970
    • Peng, G.1    Li, S.2    Wu, W.3    Tan, X.4    Chen, Y.5    Chen, Z.6
  • 50
    • 0033066049 scopus 로고    scopus 로고
    • HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines
    • PMID:10193426
    • Schlaak JF, Tully G, Löhr HF, Gerken G, Meyer zum Büschenfelde KH. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol 1999; 115: 508-514 [PMID:10193426]
    • (1999) Clin Exp Immunol , vol.115 , pp. 508-514
    • Schlaak, J.F.1    Tully, G.2    Löhr, H.F.3    Gerken, G.4    Meyerzum Büschenfelde, K.H.5
  • 51
    • 0025250037 scopus 로고
    • Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection
    • PMID: 1969983
    • Daniels HM, Meager A, Eddleston AL, Alexander GJ, Williams R. Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet 1990; 335: 875-877 [PMID: 1969983]
    • (1990) Lancet , vol.335 , pp. 875-877
    • Daniels, H.M.1    Meager, A.2    Eddleston, A.L.3    Alexander, G.J.4    Williams, R.5
  • 53
    • 34249885360 scopus 로고    scopus 로고
    • Chronic infections with hepatotropic viruses:mechanisms of impairment of cellular immune responses
    • PMID: 17520515
    • Rehermann B. Chronic infections with hepatotropic viruses:mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007; 27: 152-160 [PMID: 17520515]
    • (2007) Semin Liver Dis , vol.27 , pp. 152-160
    • Rehermann, B.1
  • 54
    • 34548125305 scopus 로고    scopus 로고
    • Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells
    • PMID: 17676045
    • Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-949 [PMID: 17676045]
    • (2007) Nat Immunol , vol.8 , pp. 942-949
    • Acosta-Rodriguez, E.V.1    Napolitani, G.2    Lanzavecchia, A.3    Sallusto, F.4
  • 55
    • 58049194071 scopus 로고    scopus 로고
    • Emergence of the Th17 pathway and its role in host defense
    • PMID: 19117534
    • O'Quinn DB, Palmer MT, Lee YK, Weaver CT. Emergence of the Th17 pathway and its role in host defense. Adv Immunol 2008; 99:115-163 [PMID: 19117534 DOI: 10.1016/S0065-2776(08)00605-6]
    • (2008) Adv Immunol , vol.99 , pp. 115-163
    • O'Quinn, D.B.1    Palmer, M.T.2    Lee, Y.K.3    Weaver, C.T.4
  • 56
    • 73449125874 scopus 로고    scopus 로고
    • Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B
    • PMID: 19842207
    • Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91 [PMID: 19842207 DOI:10.1002/hep.23273]
    • (2010) Hepatology , vol.51 , pp. 81-91
    • Zhang, J.Y.1    Zhang, Z.2    Lin, F.3    Zou, Z.S.4    Xu, R.N.5    Jin, L.6    Fu, J.L.7    Shi, F.8    Shi, M.9    Wang, H.F.10    Wang, F.S.11
  • 57
    • 77249158089 scopus 로고    scopus 로고
    • Implication of Th17 and Th1 cells in patients with chronic active hepatitis B
    • PMID: 19756987
    • Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010; 30: 60-67 [PMID: 19756987 DOI: 10.1007/ s10875-009-9328-2]
    • (2010) J Clin Immunol , vol.30 , pp. 60-67
    • Ge, J.1    Wang, K.2    Meng, Q.H.3    Qi, Z.X.4    Meng, F.L.5    Fan, Y.C.6
  • 58
    • 79957852623 scopus 로고    scopus 로고
    • Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B
    • PMID: 21639870
    • Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G, Gao Z, Liu H, Chen X, Zhou B. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J 2011; 8: 270 [PMID: 21639870 DOI:10.1186/1743-422X-8-270]
    • (2011) Virol J , vol.8 , pp. 270
    • Zhang, F.1    Yao, S.2    Yuan, J.3    Zhang, M.4    He, Q.5    Yang, G.6    Gao, Z.7    Liu, H.8    Chen, X.9    Zhou, B.10
  • 60
    • 65649111667 scopus 로고    scopus 로고
    • High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
    • PMID:19267406
    • Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES, Ng EK, Chan FK, Sung JJ, Chan HL. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 2009; 124: 2766-2770 [PMID:19267406 DOI: 10.1002/ijc.24281]
    • (2009) Int J Cancer , vol.124 , pp. 2766-2770
    • Wong, V.W.1    Yu, J.2    Cheng, A.S.3    Wong, G.L.4    Chan, H.Y.5    Chu, E.S.6    Ng, E.K.7    Chan, F.K.8    Sung, J.J.9    Chan, H.L.10
  • 62
    • 35148869631 scopus 로고    scopus 로고
    • Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients
    • PMID: 17919231
    • Jiang Z, Feng X, Zhang W, Gao F, Ling Q, Zhou L, Xie H, Chen Q, Zheng S. Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Liver Int 2007; 27: 1202-1208 [PMID: 17919231]
    • (2007) Liver Int , vol.27 , pp. 1202-1208
    • Jiang, Z.1    Feng, X.2    Zhang, W.3    Gao, F.4    Ling, Q.5    Zhou, L.6    Xie, H.7    Chen, Q.8    Zheng, S.9
  • 63
    • 71249084658 scopus 로고    scopus 로고
    • +49G & gt; A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population
    • PMID: 19778566
    • Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, Zhao Y, Gao C. +49G & gt; A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population. Hum Immunol 2010; 71:83-87 [PMID: 19778566 DOI: 10.1016/j.humimm.2009.09.353]
    • (2010) Hum Immunol , vol.71 , pp. 83-87
    • Gu, X.1    Qi, P.2    Zhou, F.3    Ji, Q.4    Wang, H.5    Dou, T.6    Zhao, Y.7    Gao, C.8
  • 64
    • 70349562495 scopus 로고    scopus 로고
    • Mononuclear cells in liver fibrosis
    • PMID:19533130
    • Marra F, Aleffi S, Galastri S, Provenzano A. Mononuclear cells in liver fibrosis. Semin Immunopathol 2009; 31: 345-358 [PMID:19533130 DOI: 10.1007/s00281-009-0169-0]
    • (2009) Semin Immunopathol , vol.31 , pp. 345-358
    • Marra, F.1    Aleffi, S.2    Galastri, S.3    Provenzano, A.4
  • 66
    • 0038504830 scopus 로고    scopus 로고
    • Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease
    • PMID:12858469
    • Michel M, Duvoux C, Hezode C, Cherqui D. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease. J Rheumatol 2003; 30: 1624-1625 [PMID:12858469]
    • (2003) J Rheumatol , vol.30 , pp. 1624-1625
    • Michel, M.1    Duvoux, C.2    Hezode, C.3    Cherqui, D.4
  • 67
    • 0037532694 scopus 로고    scopus 로고
    • Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate
    • PMID:12810441
    • Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S. Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 2003; 62: 686-687 [PMID:12810441]
    • (2003) Ann Rheum Dis , vol.62 , pp. 686-687
    • Ostuni, P.1    Botsios, C.2    Punzi, L.3    Sfriso, P.4    Todesco, S.5
  • 68
    • 84874013235 scopus 로고    scopus 로고
    • Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV
    • PMID: 23436024
    • Vassilopoulos D, Calabrese LH. Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV. Curr Rheumatol Rep 2013; 15: 319 [PMID: 23436024 DOI: 10.1007/s11926-013-0319-1]
    • (2013) Curr Rheumatol Rep , vol.15 , pp. 319
    • Vassilopoulos, D.1    Calabrese, L.H.2
  • 69
    • 47249104803 scopus 로고    scopus 로고
    • Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection
    • PMID: 18221983
    • Carroll MB, Bond MI. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Semin Arthritis Rheum 2008; 38: 208-217 [PMID: 18221983 DOI:10.1016/j.semarthrit.2007.10.011]
    • (2008) Semin Arthritis Rheum , vol.38 , pp. 208-217
    • Carroll, M.B.1    Bond, M.I.2
  • 71
    • 70450208567 scopus 로고    scopus 로고
    • Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy
    • PMID: 19797507
    • Chung SJ, Kim JK, Park MC, Park YB, Lee SK. Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy. J Rheumatol 2009; 36:2416-2420 [PMID: 19797507 DOI: 10.3899/jrheum.081324]
    • (2009) J Rheumatol , vol.36 , pp. 2416-2420
    • Chung, S.J.1    Kim, J.K.2    Park, M.C.3    Park, Y.B.4    Lee, S.K.5
  • 72
    • 77953102456 scopus 로고    scopus 로고
    • Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases
    • Hoboken, PMID: 20535784
    • Caporali R, Bobbio-Pallavicini F, Atzeni F, Sakellariou G, Caprioli M, Montecucco C, Sarzi-Puttini P. Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases. Arthritis Care Res (Hoboken) 2010; 62:749-754 [PMID: 20535784 DOI: 10.1002/acr.20130]
    • (2010) Arthritis Care Res , vol.62 , pp. 749-754
    • Caporali, R.1    Bobbio-Pallavicini, F.2    Atzeni, F.3    Sakellariou, G.4    Caprioli, M.5    Montecucco, C.6    Sarzi-Puttini, P.7
  • 74
    • 84855667800 scopus 로고    scopus 로고
    • Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological diseasemodifying antirheumatic drugs
    • PMID: 21528424
    • Mori S. Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological diseasemodifying antirheumatic drugs. Mod Rheumatol 2011; 21: 621-627 [PMID: 21528424 DOI: 10.1007/s10165-011-0458-z]
    • (2011) Mod Rheumatol , vol.21 , pp. 621-627
    • Mori, S.1
  • 75
    • 79959848770 scopus 로고    scopus 로고
    • Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy:evaluation of both HBsAg-positive and HBsAg-negative cohorts
    • PMID: 21246383
    • Tamori A, Koike T, Goto H, Wakitani S, Tada M, Morikawa H, Enomoto M, Inaba M, Nakatani T, Hino M, Kawada N. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy:evaluation of both HBsAg-positive and HBsAg-negative cohorts. J Gastroenterol 2011; 46: 556-564 [PMID: 21246383 DOI: 10.1007/ s00535-010-0367-5]
    • (2011) J Gastroenterol , vol.46 , pp. 556-564
    • Tamori, A.1    Koike, T.2    Goto, H.3    Wakitani, S.4    Tada, M.5    Morikawa, H.6    Enomoto, M.7    Inaba, M.8    Nakatani, T.9    Hino, M.10    Kawada, N.11
  • 77
    • 80052514253 scopus 로고    scopus 로고
    • Kinetics of viral load and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumor necrosis factor therapy
    • Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS. Kinetics of viral load and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumor necrosis factor therapy. Ann Rheum Dis 2011; 70:1719-1725
    • (2011) Ann Rheum Dis , vol.70 , pp. 1719-1725
    • Lan, J.L.1    Chen, Y.M.2    Hsieh, T.Y.3    Chen, Y.H.4    Hsieh, C.W.5    Chen, D.Y.6    Yang, S.S.7
  • 78
    • 84886524794 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing antitumor necrosis factor therapy or DMARDs
    • PMID: 24164839
    • Lee YH, Bae SC, Song GG. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing antitumor necrosis factor therapy or DMARDs. Int J Rheum Dis 2013; 16: 527-531 [PMID: 24164839 DOI: 10.1111/1756-185X.12154]
    • (2013) Int J Rheum Dis , vol.16 , pp. 527-531
    • Lee, Y.H.1    Bae, S.C.2    Song, G.G.3
  • 79
    • 84874818081 scopus 로고    scopus 로고
    • Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy
    • PMID: 23111095
    • Lee YH, Bae SC, Song GG. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 2013; 31: 118-121 [PMID: 23111095]
    • (2013) Clin Exp Rheumatol , vol.31 , pp. 118-121
    • Lee, Y.H.1    Bae, S.C.2    Song, G.G.3
  • 81
    • 84897352169 scopus 로고    scopus 로고
    • Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
    • Apr 4, Epub ahead of print [PMID:24698305
    • Nakamura J, Nagashima T, Nagatani K, Yoshio T, Iwamoto M, Minota S. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs. Int J Rheum Dis 2014 Apr 4; Epub ahead of print [PMID:24698305 DOI: 10.1111/1756-185X.12359]
    • (2014) Int J Rheum Dis
    • Nakamura, J.1    Nagashima, T.2    Nagatani, K.3    Yoshio, T.4    Iwamoto, M.5    Minota, S.6
  • 82
    • 84922576890 scopus 로고    scopus 로고
    • Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation
    • PMID:24561021
    • Lunel-Fabiani F, Masson C, Ducancelle A. Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation. Joint Bone Spine 2014; 81: 478-484 [PMID:24561021 DOI: 10.1016/j.jbspin.2014.01.015]
    • (2014) Joint Bone Spine , vol.81 , pp. 478-484
    • Lunel-Fabiani, F.1    Masson, C.2    Ducancelle, A.3
  • 83
    • 0026088152 scopus 로고
    • Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study
    • PMID: 1983820
    • Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188 [PMID: 1983820]
    • (1991) Gastroenterology , vol.100 , pp. 182-188
    • Lok, A.S.1    Liang, R.H.2    Chiu, E.K.3    Wong, K.L.4    Chan, T.K.5    Todd, D.6
  • 84
    • 59149085061 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab
    • PMID: 19075267
    • Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009; 27:605-611 [PMID: 19075267 DOI: 10.1200/JCO.2008.18.0182]
    • (2009) J Clin Oncol , vol.27 , pp. 605-611
    • Yeo, W.1    Chan, T.C.2    Leung, N.W.3    Lam, W.Y.4    Mo, F.K.5    Chu, M.T.6    Chan, H.L.7    Hui, E.P.8    Lei, K.I.9    Mok, T.S.10    Chan, P.K.11
  • 85
    • 0016434332 scopus 로고
    • Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders
    • PMID: 1054319
    • Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975; 68: 105-112 [PMID: 1054319]
    • (1975) Gastroenterology , vol.68 , pp. 105-112
    • Wands, J.R.1    Chura, C.M.2    Roll, F.J.3    Maddrey, W.C.4
  • 86
    • 80055100653 scopus 로고    scopus 로고
    • Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
    • PMID: 21520001
    • Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis. Ann Hematol 2011; 90:1219-1223 [PMID: 21520001 DOI: 10.1007/s00277-011-1241-0]
    • (2011) Ann Hematol , vol.90 , pp. 1219-1223
    • Koo, Y.X.1    Tay, M.2    Teh, Y.E.3    Teng, D.4    Tan, D.S.5    Tan, I.B.6    Tai, D.W.7    Quek, R.8    Tao, M.9    Lim, S.T.10
  • 87
    • 84928968951 scopus 로고    scopus 로고
    • The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximabbased chemotherapy
    • Aug 19, Epub ahead of print [PMID: 25065698]
    • Lu S, Xu Y, Mu Q, Cao L, Chen J, Zhu Z, Lou Y, Meng H, Qian W, Tong H, Mai W, Huang J, Yu W, Zhao X, Jin J. The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximabbased chemotherapy. Leuk Lymphoma 2014 Aug 19; Epub ahead of print [PMID: 25065698]
    • (2014) Leuk Lymphoma
    • Lu, S.1    Xu, Y.2    Mu, Q.3    Cao, L.4    Chen, J.5    Zhu, Z.6    Lou, Y.7    Meng, H.8    Qian, W.9    Tong, H.10    Mai, W.11    Huang, J.12    Yu, W.13    Zhao, X.14    Jin, J.15
  • 88
    • 79954436710 scopus 로고    scopus 로고
    • Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis
    • PMID: 19830433
    • Pyrpasopoulou A, Douma S, Vassiliadis T, Chatzimichailidou S, Triantafyllou A, Aslanidis S. Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis. Rheumatol Int 2011; 31: 403-404 [PMID: 19830433 DOI:10.1007/s00296-009-1202-2]
    • (2011) Rheumatol Int , vol.31 , pp. 403-404
    • Pyrpasopoulou, A.1    Douma, S.2    Vassiliadis, T.3    Chatzimichailidou, S.4    Triantafyllou, A.5    Aslanidis, S.6
  • 89
    • 84855690103 scopus 로고    scopus 로고
    • Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis
    • PMID:21944979
    • Ghrénassia E, Mékinian A, Rouaghe S, Ganne N, Fain O. Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis. Joint Bone Spine 2012; 79: 100-101 [PMID:21944979 DOI: 10.1016/j.jbspin.2011.07.003]
    • (2012) Joint Bone Spine , vol.79 , pp. 100-101
    • Ghrénassia, E.1    Mékinian, A.2    Rouaghe, S.3    Ganne, N.4    Fain, O.5
  • 90
    • 84879702684 scopus 로고    scopus 로고
    • Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab
    • PMID: 23935355
    • Gigi E, Georgiou T, Mougiou D, Boura P, Raptopoulou-Gigi M. Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab. Hippokratia 2013; 17: 91-93 [PMID: 23935355]
    • (2013) Hippokratia , vol.17 , pp. 91-93
    • Gigi, E.1    Georgiou, T.2    Mougiou, D.3    Boura, P.4    Raptopoulou-Gigi, M.5
  • 91
    • 84872060358 scopus 로고    scopus 로고
    • Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
    • PMID: 22930597
    • Mitroulis I, Hatzara C, Kandili A, Hadziyannis E, Vassilopoulos D. Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis 2013; 72: 308-310 [PMID: 22930597 DOI: 10.1136/ annrheumdis-2012-202088]
    • (2013) Ann Rheum Dis , vol.72 , pp. 308-310
    • Mitroulis, I.1    Hatzara, C.2    Kandili, A.3    Hadziyannis, E.4    Vassilopoulos, D.5
  • 92
    • 56649094588 scopus 로고    scopus 로고
    • Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B
    • Oxford, PMID: 18854348
    • Nagashima T, Minota S. Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B. Rheumatology (Oxford) 2008; 47: 1838-1840 [PMID: 18854348 DOI: 10.1093/rheumatology/ken384]
    • (2008) Rheumatology , vol.47 , pp. 1838-1840
    • Nagashima, T.1    Minota, S.2
  • 93
    • 84855681277 scopus 로고    scopus 로고
    • A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximabreactivated hepatitis B
    • PMID:21626075
    • Tsuboi H, Tsujii A, Nampei A, Yoshihara H, Kawano K, Takeuchi E, Shi K. A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximabreactivated hepatitis B. Mod Rheumatol 2011; 21: 701-705 [PMID:21626075 DOI: 10.1007/s10165-011-0470-3]
    • (2011) Mod Rheumatol , vol.21 , pp. 701-705
    • Tsuboi, H.1    Tsujii, A.2    Nampei, A.3    Yoshihara, H.4    Kawano, K.5    Takeuchi, E.6    Shi, K.7
  • 94
    • 79959933001 scopus 로고    scopus 로고
    • Successful tocilizumab treatment in a patient with adult-onset Still' s disease complicated by chronic active hepatitis B and amyloid A amyloidosis
    • PMID: 20931272
    • Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K, Jouyama K, Yamada A, Sawada N, Mokuda S, Takasugi K. Successful tocilizumab treatment in a patient with adult-onset Still' s disease complicated by chronic active hepatitis B and amyloid A amyloidosis. Mod Rheumatol 2011; 21: 215-218 [PMID: 20931272 DOI: 10.1007/s10165-010-0365-8]
    • (2011) Mod Rheumatol , vol.21 , pp. 215-218
    • Kishida, D.1    Okuda, Y.2    Onishi, M.3    Takebayashi, M.4    Matoba, K.5    Jouyama, K.6    Yamada, A.7    Sawada, N.8    Mokuda, S.9    Takasugi, K.10
  • 95
    • 84864457039 scopus 로고    scopus 로고
    • Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B
    • Hoboken, PMID: 22392695
    • Kim PS, Ho GY, Prete PE, Furst DE. Safety and efficacy of abatacept in eight rheumatoid arthritis patients with chronic hepatitis B. Arthritis Care Res (Hoboken) 2012; 64: 1265-1268 [PMID: 22392695 DOI: 10.1002/acr.21654]
    • (2012) Arthritis Care Res , vol.64 , pp. 1265-1268
    • Kim, P.S.1    Ho, G.Y.2    Prete, P.E.3    Furst, D.E.4
  • 96
    • 84861185389 scopus 로고    scopus 로고
    • Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept
    • PMID: 22127282
    • Germanidis G, Hytiroglou P, Zakalka M, Settas L. Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept. J Hepatol 2012; 56: 1420-1421 [PMID: 22127282 DOI: 10.1016/j.jhep.2011.10.011]
    • (2012) J Hepatol , vol.56 , pp. 1420-1421
    • Germanidis, G.1    Hytiroglou, P.2    Zakalka, M.3    Settas, L.4
  • 97
    • 0025152480 scopus 로고
    • The management and utilisation of operating departments. A review of the Bevan Report
    • PMID:2377195
    • Bell A. The management and utilisation of operating departments. A review of the Bevan Report. NATNEWS 1990; 27: 5-7 [PMID:2377195 DOI: 10.1093/rheumatology/ket221]
    • (1990) NATNEWS , vol.27 , pp. 5-7
    • Bell, A.1
  • 98
    • 84928948804 scopus 로고    scopus 로고
    • Safety of the newer biological DMARDs, tocilizumab and abatacept, in rheumatoid arthritis patients with a history of HBV infection: a real life experience. Proceedings of the European League Against Rheumatism Congress; 2014 June 11-14; Paris, France
    • De Nard F, Todoerti M, Grosso V, Rossi S, Caporali R, Montecucco C. Safety of the newer biological DMARDs, tocilizumab and abatacept, in rheumatoid arthritis patients with a history of HBV infection: a real life experience. Proceedings of the European League Against Rheumatism Congress; 2014 June 11-14; Paris, France. Ann Rheum Dis 2014; 73: 499 [DOI: 10.1136/annrheumdis-2014-eular.5021]
    • (2014) Ann Rheum Dis , vol.73 , pp. 499
    • De Nard, F.1    Todoerti, M.2    Grosso, V.3    Rossi, S.4    Caporali, R.5    Montecucco, C.6
  • 100
    • 84861483244 scopus 로고    scopus 로고
    • Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment
    • PMID: 22037116
    • Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev 2012; 11: 572-576 [PMID: 22037116 DOI: 10.1016/ j.autrev.2011.10.015]
    • (2012) Autoimmun Rev , vol.11 , pp. 572-576
    • Bijl, M.1    Agmon-Levin, N.2    Dayer, J.M.3    Israeli, E.4    Gatto, M.5    Shoenfeld, Y.6
  • 101
    • 22144450985 scopus 로고    scopus 로고
    • A case-control study of serious autoimmune adverse events following hepatitis B immunization
    • PMID: 16206512
    • Geier DA, Geier MR. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38: 295-301 [PMID: 16206512]
    • (2005) Autoimmunity , vol.38 , pp. 295-301
    • Geier, D.A.1    Geier, M.R.2
  • 103
    • 79151484198 scopus 로고    scopus 로고
    • 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants
    • PMID:20708902
    • Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4-8 [PMID:20708902 DOI: 10.1016/j.jaut.2010.07.003]
    • (2011) J Autoimmun , vol.36 , pp. 4-8
    • Shoenfeld, Y.1    Agmon-Levin, N.2
  • 105
    • 0036900993 scopus 로고    scopus 로고
    • A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database
    • PMID: 12508767
    • Geier DA, Geier MR. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol 2002; 20: 767-771 [PMID: 12508767]
    • (2002) Clin Exp Rheumatol , vol.20 , pp. 767-771
    • Geier, D.A.1    Geier, M.R.2
  • 106
    • 0036296054 scopus 로고    scopus 로고
    • Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis
    • PMID: 12079904
    • Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 623-625 [PMID: 12079904]
    • (2002) Ann Rheum Dis , vol.61 , pp. 623-625
    • Elkayam, O.1    Yaron, M.2    Caspi, D.3
  • 107
    • 84860551562 scopus 로고    scopus 로고
    • Usefulness of routine hepatitis C and hepatitis B serology in the diagnosis of recent-onset arthritis. Systematic prospective screening in all patients seen by the rheumatologists of a defined area--brief report
    • PMID: 21733731
    • Ansemant T, Ornetti P, Garrot JF, Pascaud F, Tavernier C, Maillefert JF. Usefulness of routine hepatitis C and hepatitis B serology in the diagnosis of recent-onset arthritis. Systematic prospective screening in all patients seen by the rheumatologists of a defined area--brief report. Joint Bone Spine 2012; 79: 268-270 [PMID: 21733731 DOI: 10.1016/j.jbspin.2011.05.019]
    • (2012) Joint Bone Spine , vol.79 , pp. 268-270
    • Ansemant, T.1    Ornetti, P.2    Garrot, J.F.3    Pascaud, F.4    Tavernier, C.5    Maillefert, J.F.6
  • 109
    • 0023676508 scopus 로고
    • Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs
    • PMID: 2968945
    • Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988; 8: 766-770 [PMID: 2968945]
    • (1988) Hepatology , vol.8 , pp. 766-770
    • Lok, A.S.1    Lai, C.L.2    Wu, P.C.3
  • 110
    • 77951725797 scopus 로고    scopus 로고
    • Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy
    • Hoboken, PMID:20461789
    • Stine JG, Khokhar OS, Charalambopoulos J, Shanmugam VK, Lewis JH. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) 2010; 62: 704-711 [PMID:20461789 DOI: 10.1002/acr.20209]
    • (2010) Arthritis Care Res , vol.62 , pp. 704-711
    • Stine, J.G.1    Khokhar, O.S.2    Charalambopoulos, J.3    Shanmugam, V.K.4    Lewis, J.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.